Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 6055-19-2 | Product Number: C2236
Cyclophosphamide Monohydrate
Purity: >98.0%(N)
- 2-[Bis(2-chloroethyl)amino]tetrahydro-1,3,2-oxazaphosphorin-2-oxide Monohydrate
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | C2236 |
Purity / Analysis Method
|
>98.0%(N) |
| Molecular Formula / Molecular Weight | C__7H__1__5Cl__2N__2O__2P·H__2O = 279.10 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Air Sensitive,Heat Sensitive |
| CAS RN | 6055-19-2 |
Related CAS RN
|
50-18-0 |
| Reaxys Registry Number | 8167897 |
| PubChem Substance ID | 125307342 |
| Merck Index (14) | 2747 |
| MDL Number | MFCD00149395 |
| Appearance | White to Almost white powder to crystal |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Melting point | 49.0 to 53.0 °C |
| Water | max. 8.0 % |
| NMR | confirm to structure |
| Melting Point | 51 °C |
| Solubility in water | Slightly soluble |
| Solubility (soluble in) | Ether |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. H315 : Causes skin irritation. H362 : May cause harm to breast-fed children. H340 : May cause genetic defects. H350 : May cause cancer. |
| Precautionary Statements | P263 : Avoid contact during pregnancy and while nursing. P260 : Do not breathe dust. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. |
| EC Number | 200-015-4 |
| RTECS# | RP6157750 |
| UN Number | UN3464 |
| Class | 6.1 |
| Packing Group | III |
| HS Number | 2934999090 |
References
- Uroprotective effect of pentoxifylline in cyclophosphamide-induced hemorrhagic cystitis in rats
- Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder
- Effect of intrathecal administration of E-series prostaglandin 1 receptor antagonist in a cyclophosphamide-induced cystitis rat model
- Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model
References
- A rabbit used as a model for testing hematopoietic tissue transplants
- S. Kosi?ski, H. Matej, Arch. Immunol. Ther. Exp. (Warsz) 1978, 26, 1021.
- Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia
References
- Cyclophosphamide cystitis--identification of acrolein as the causative agent
- Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents
- Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation
- Cyclophosphamide cystitis in mice: behavioural characterisation and correlation with bladder inflammation
- Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain
- Comparison of voiding function and nociceptive behavior in two rat models of cystitis induced by cyclophosphamide or acetone
References
- The antiemetic effect of a novel tropisetron patch in anticancer agents-induced kaolin pica model using rats
- The anti-cancer drug-induced pica in rats is related to their clinical emetogenic potential
References
- An overview of cyclophosphamide and ifosfamide pharmacology
- R. A. Fleming, Pharmacotherapy 1997, 17, 146S.
- Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks
- The chemistry of the metabolites of cyclophosphamide
- S. M. Ludeman, Curr. Pharm. Des. 1999, 5, 627.
- Mechanisms of resistance to the toxicity of cyclophosphamide
- M. P. Gamcsik, M. E. Dolan, B. S. Andersson, D. Murray, Curr. Pharm. Des. 1999, 5, 587.
Reference
Reference
- Optical resolution studies of cyclophosphamide
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.